共 50 条
- [31] How to identify the rapid progression patients in the autosomal dominant polycystic kidney disease? NEPHROLOGIE & THERAPEUTIQUE, 2016, 12 : S13 - S15
- [33] Review of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease PHARMACOTHERAPY, 2014, 34 (06): : 605 - 616
- [34] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease Drugs, 2015, 75 : 1797 - 1806
- [39] Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience Clinical and Experimental Nephrology, 2013, 17 : 345 - 351